Sabesp, Brava, Ultrapar e Plano&Plano: o que mudaram JP Morgan, XP e Morgan Stanley?

Sabesp, Brava, Ultrapar e Plano&Plano: o que mudaram JP Morgan, XP e Morgan Stanley?

Analyzed Watch on YouTube Requested On
Video return
Calls
4
Buy / Sell
3 1
Published

Recommendations

Entry is the asset's closing price on the publication date. Current is the last close on record.

  1. 01 SBSP3 B3 BUY +0.00%
    Entry R$26.83 08 Sep 2026
    Current R$26.83 08 Sep 2026
    Result +R$0.00
    vs. index +0.0% BOVA11 +0.0% over the same days

    They reiterate their buy rating and raise it from 34 to 35.

    AI-extracted context JPMorgan has just raised the target price for Sabesp. Oh, this is an interesting move. They reiterate their buy rating and raise it from 34 to 35.

  2. 02 SBSP3 B3 BUY +0.00%
    Entry R$26.83 08 Sep 2026
    Current R$26.83 08 Sep 2026
    Result +R$0.00
    vs. index +0.0% BOVA11 +0.0% over the same days

    XP maintains its buy rating

    AI-extracted context XP maintains its buy rating, and, roughly speaking, it also still has a higher target price than JPMorgan, right?

  3. 03 UGPA3 B3 BUY +0.00%
    Entry R$38.04 08 Sep 2026
    Current R$38.04 08 Sep 2026
    Result +R$0.00
    vs. index +0.0% BOVA11 +0.0% over the same days

    The bank indicates a buy

    AI-extracted context For JP Morgan, Ultrapar is still an excellent opportunity. The bank indicates a buy, has a target price of 39; look, it's close, 38, 39.

  4. 04 PLPL3 B3 SELL +0.00%
    Entry R$7.40 08 Sep 2026
    Current R$7.40 08 Sep 2026
    Result +R$0.00
    vs. index +0.0% BOVA11 +0.0% over the same days
    Surrounding source transcript
    …keeping an eye on all the movements, making cuts in some cases. In this movement, Plano e Plano was, in fact, the one that got hit the hardest, you know? Morgan Stanley downgraded it, did a double downgrade for Plano e Plano shares, moved it from buy to sell. It even cut the target price from 17 to 7.50. Currently, we are close to that, 7.30, you see? And we can't forget that in March, right, February, March, February of this year, we had Plano e Plano stock at 16 reais. It was close to t…

    moved it from buy to sell.

    AI-extracted context Morgan Stanley downgraded it, did a double downgrade for Plano e Plano shares, moved it from buy to sell.

Full Transcript
Coming up with the market pointers and recommendations. Banks and brokerages are looking at the stocks, at the shares traded on the Brazilian stock exchange. JPMorgan has just raised the target price for Sabesp. Oh, this is an interesting move. They reiterate their buy rating and raise it from 34 to 35. It is currently at 27 Brazilian reais. The stock's all-time high was exactly that, 35.32. For those who don't remember, at the time of the privatization, there was talk of 80 or 100 reais for a Sabesp share. Why 35? Because there was a stock split, you see? Later, there was a five-for-one split. So, it is natural to notice this movement if you are thinking back to that time. But today, this is the reference point. 27 reais is more or less what Sabesp shares are orbiting around. JPMorgan states that after a meeting with the company's board, the conversation flowed and was very constructive in showing that Sabesp's current management sees ample room for cost-cutting within the company, which could boost Sabesp's revenue. JPMorgan is raising the target price in a move exactly opposite to what XP did last week. Last week, XP cut the target price from 8.30 to 6.80 reais. But it's worth noting, XP maintains its buy rating and, roughly speaking, it also still has a higher target price than JPMorgan, right? So, XP, even with the cut, is at 6.80 reais. JPMorgan is now at 35 reais. The oil sector remains very active, Brava Energia has recommendations here, it is in the market's focus for many banks, brokerages, and financial institutions, keeping an eye on the current movement and where these Brava Energia shares are headed. Currently at 18 reais, right? It has been orbiting this value between 16 and 18 reais over the last month. XP has a buy recommendation, while JPMorgan has a neutral recommendation. The target price also changes. XP talks about 26 reais for Brava. JPMorgan talks about 20 reais. According to XP, pressures from the slight reduction in production at Papa Terra and Atlanta were offset by the operational recovery at Parque das Conchas and the stability of other assets. So the bank is keeping an eye on the production report released by Brava Energia. In that same report, JPMorgan points out that the company's production in August beat the bank's expectations, even though it was 1.1% lower compared to the previous quarter. And all of this, this drop when comparing quarter over quarter, has to do with maintenance. But according to JP Morgan, even coming in below the previous quarter, production exceeded the bank's expectations, which is why it maintains a neutral recommendation. XP indicates a buy, and just to repeat the target price: XP at 26, JP Morgan at 20 reais. Brava Energia. Arriving with more indications and recommendations, now the stock here on the Nelógica Profit screen is Ultrapar . The year 2026 has been very good for Ultrapar, okay? It started here with a stock around 20, 23, 24 reais. Then it had a slight dip, returned to the 22 level, and from there, from June onwards, it only went up in an ascending staircase. We're talking about 38 reais, the value, the year's high, including its best historical performance, not to forget Ultrapar here with this stock. Therefore, as we are seeing there, 38 reais was this year's high and the all-time high as well. Currently, it's a little bit below that. For JP Morgan, Ultrapar is still an excellent opportunity. The bank indicates a buy, has a target price of 39; look, it's close, 38, 39. The company continues to differentiate itself from its peers, according to the bank, mainly because it consolidates a diversified holding structure anchored in an active and integrated capital allocation strategy. Sufficient reasons for the bank to understand that Ultrapar, the Ultrapar stock, is an important stock to have in your portfolio. The target price, therefore, is 39, right? I was talking a moment ago about the 38 all-time high; now Ultrapar's stock is at 37 and change. And the recommendation, just to reinforce, is a buy for Ultrapar. Let's continue. Morgan Stanley is reviewing all assets in the real estate sector of the Brazilian market. It's keeping an eye on all the movements, making cuts in some cases. In this movement, Plano e Plano was, in fact, the one that got hit the hardest, you know? Morgan Stanley downgraded it, did a double downgrade for Plano e Plano shares, moved it from buy to sell. It even cut the target price from 17 to 7.50. Currently, we are close to that, 7.30, you see? And we can't forget that in March, right, February, March, February of this year, we had Plano e Plano stock at 16 reais. It was close to the 17 proposed by Morgan Stanley and then it only fell. A strong downward movement. Now we are talking about 7.30 and this target price from Morgan Stanley is now 7.50. But it is important to remember, the recommendation changes from buy to sell . This reduction is approximately 56%. The bank is revising its entire coverage of the real estate sector and cites a more cautious stance given electoral and fiscal uncertainties, still-high interest rates, the SELIC, and the risk of an economic slowdown in 2027. All of this could directly impact the developers and construction companies sector here. The cyclical sector should suffer under this scenario.

Comments 0

No comments yet. Be the first to share your thoughts!